tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Medical Data Vision Revises 2025 Financial Forecasts Amid Sales Delays

Story Highlights
Medical Data Vision Revises 2025 Financial Forecasts Amid Sales Delays

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from Medical Data Vision Co.Ltd. ( (JP:3902) ) is now available.

Medical Data Vision has revised its financial forecasts for the fiscal year ending December 31, 2025, due to lower-than-expected net sales and profits. Despite achieving record sales in the first half of the year, delays in the installation of the ‘ALPHA ・SALUS’ system and a careful examination of prospective projects have led to a significant downward revision. The company continues to invest in future growth, particularly by expanding its sales personnel, but expects operating income, ordinary income, and net income to be considerably lower than initially projected.

More about Medical Data Vision Co.Ltd.

Medical Data Vision Co., Ltd. operates in the healthcare industry, focusing on data utilization services and cloud-based medical checkup systems, such as the ‘ALPHA ・SALUS’.

Average Trading Volume: 262,870

Technical Sentiment Signal: Hold

Current Market Cap: Yen21.45B

For detailed information about 3902 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1